(lp0
S'SciClone Pharmaceuticals: Beyond The Death Of A Sales Process Seeking Alpha - Feb 2, 2017 SciClone Pharmaceuticals  is a revenue-generating pharmaceutical company with a portfolio of HBV/HCV, oncology, anti-infection and cardiovascular drug candidates.'
p1
aS'Why SciClone Pharmaceuticals, Inc. Is Surging Higher Motley Fool - Mar 12, 2015 What: Shares in SciClone Pharmaceuticals  jumped by nearly 10% today after reporting fourth quarter and full year earnings results after the bell yesterday.'
p2
aS'9.60 MarketWatch - Oct 28, 2009 SciClone Pharmaceuticals Inc. SciClone Pharmaceuticals, Inc. engages in the development of therapeutics treatment for cancer, infectious diseases, and cardiovascular disorders.'
p3
aS'SciClone Confirms Receipt Of Unsolicited Proposal From GL Capital And ABG ... PR Newswire  - Nov 14, 2016 FOSTER CITY, Calif., Nov. 14, 2016 /PRNewswire/ -- SciClone Pharmaceuticals, Inc.   today confirmed that it has received an unsolicited, nonbinding proposal from a consortium led by GL Capital Management GP Limited and&nbsp;...'
p4
aS"SciClone Announces Progress In Advancing Clinical Pipeline For China ... PR Newswire  - Sep 26, 2016 26, 2016 /PRNewswire/ -- SciClone Pharmaceuticals, Inc.  today announced two important achievements in advancing the Company's clinical pipeline and development portfolio in Greater China."
p5
aS'SciClone Pharmaceuticals Inc. SCLN  Wall Street Journal - Feb 12, 2011 News SciClone Pharmaceuticals Inc.SCLN. Significant News Only. 03/27/17; Press Release. SciClone To Present At Needham Healthcare Conference On April 4, 2017.'
p6
aS'Sciclone Pharmaceuticals Inc  President &amp; CEO Friedhelm Blobel Sold $5 ... Nasdaq - Aug 19, 2016 SciClone Pharmaceuticals Inc is a specialty pharmaceutical company with a substantial commercial business in China and a product portfolio of therapies for oncology, infectious diseases and cardiovascular disorders.'
p7
aS"SciClone Pharmaceuticals'  CEO Friedhelm Blobel on Q4 2016 Results ... Seeking Alpha - Mar 6, 2017 SciClone would like you to thank you for joining the call today. The Company would also like to remind you that today's call is being recorded.SciClone posts 4Q profit - Yahoo Finance"
p8
aS"SciClone Pharmaceuticals' stock tumbles after ending discussions with acquirers MarketWatch - Jul 19, 2016 Shares of SciClone Pharmaceuticals Inc. SCLN, -1.03% plunged 21% in premarket trade Tuesday, after the drugmaker said it was no longer continuing active discussions with potential acquirers."
p9
aS'SciClone Pharmaceuticals, Inc.  CEO Friedhelm Blobel Sells 40000 Shares The Cerbat Gem - Apr 16, 2017 SciClone Pharmaceuticals logo SciClone Pharmaceuticals, Inc.  CEO Friedhelm Blobel sold 40,000 shares of SciClone Pharmaceuticals stock in a transaction on Wednesday, March 22nd.The Analytic Investors LLC Acquires Shares of 78322 SciClone Pharmaceuticals ... - Petro Global News 24'
p10
a.